## Background: The prevalence and clinical characteristics of dystonia in huntington's disease (hd) have not been formally assessed. ## Objectives: To study (1) the prevalence of dystonia in hd in a clinic population, (2) the clinical features of dystonia, and (3) clinical correlates of dystonia
Juvenile onset Huntington's disease?clinical and research perspectives
β Scribed by Nance, Martha A. ;Myers, Richard H.
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 124 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1080-4013
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Huntington's disease (HD) is an inherited neurodegenerative disorder. The mutation which causes the disease is an expansion in the number of repetitions of three nucleotides, C, A, and G in exon 1 of the huntingtin gene. The gene normally has 15 to 30 repeats and an expansion to 40 or more is associated with HD. HD usually has a midβlife onset, but a juvenile form, defined by onset of symptoms before the age of 21 years, is present in about 7% of HD cases. Juvenile HD is characterized by (1) transmission from an HD affected father, (2) an unusually large repeat size, usually of 60 or more units, and (3) unique clinical features, including rigidity and seizure disorder. Although juvenile onset is associated with a more severe neuropathological involvement, the neuropathological characteristics of juvenile HD are similar to those seen in the adult form in that the striatum bears the brunt of the illness. Clumps of protein, termed inclusion bodies, which stain positive for huntingtin and ubiquitin, are found primarily in the nucleus but also in the cytoplasm and axons in HD neurons. Research suggests that these inclusion bodies sequester a deleterious protein fragment and prolong cell life during the degenerative process of the disease. MRDD Research Reviews 2001;7:153β157. Β© 2001 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HDβlike symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cau
## Abstract We report the characteristics of 691 Mexican patients with Huntington's disease (HD). These patients, representing 401 families, constitute the largest series of Mexican HD cases as yet described in the literature. We found the clinical characteristics of these patients to be similar to
## Abstract Huntington's disease is a neurodegenerative condition, characterized by movement disorders, cognitive decline, and psychiatric disturbance. We review the pharmacological management of the various movement disorders associated with the disease, the cognitive decline and the commonly enco